Cargando…

Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies

BACKGROUND: Current German and European guidelines suggest migraine patients undertake a treatment break after 9 to 12 months of treatment with CGRP (pathway) monoclonal antibodies. METHODS: Clinical routine data of highly resistant migraine patients were analyzed before treatment with CGRP monoclon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nsaka, Michael, Scheffler, Armin, Wurthmann, Sebastian, Schenk, Hannah, Kleinschnitz, Christoph, Glas, Martin, Holle, Dagny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304830/ https://www.ncbi.nlm.nih.gov/pubmed/35687795 http://dx.doi.org/10.1002/brb3.2662

Ejemplares similares

CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
por: Scheffler, Armin, et al.
Publicado: (2021)

Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
por: Schenk, Hannah, et al.
Publicado: (2022)

Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
por: Scheffler, Armin, et al.
Publicado: (2020)

Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study
por: Wurthmann, Sebastian, et al.
Publicado: (2021)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data
por: Pavelic, Antun R., et al.
Publicado: (2022)

Persistent Postural-Perceptual Dizziness: A Matter of Higher, Central Dysfunction?
por: Holle, Dagny, et al.
Publicado: (2015)

Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Cooling Off and the Effects of Mandatory Breaks in Online Gambling: A Large-Scale Real-World Study
por: Hopfgartner, Niklas, et al.
Publicado: (2023)

Calcitonin Gene–Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison
por: Lu, Jiajie, et al.
Publicado: (2021)

Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking
por: Manoukian, Raffi, et al.
Publicado: (2019)

Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention
por: Morgan, Kelsey Woods, et al.
Publicado: (2021)

Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil
por: Holle, Dagny, et al.
Publicado: (2013)

Editorial: Calcitonin Gene-Related Peptide: Novel Biology and Treatments
por: Brain, Susan D., et al.
Publicado: (2022)

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
por: Scuteri, Damiana, et al.
Publicado: (2019)

Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide and Its Receptor in Japanese Adolescents With Migraines
por: Katsuki, Masahito, et al.
Publicado: (2023)

The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes
por: Sekiguchi, Toshio
Publicado: (2018)

The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis
por: Fernández-Bravo-Rodrigo, Jaime, et al.
Publicado: (2022)

Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study
por: Varnado, Oralee J, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis
por: Chen, Yao-Yao, et al.
Publicado: (2021)

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis
por: Deng, Hong, et al.
Publicado: (2020)

Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine
por: Pederson, Susan, et al.
Publicado: (2021)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
por: Cohen, Fred, et al.
Publicado: (2022)

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Mandatory treatment for methamphetamine use in Australia
por: Coleman, Mathew, et al.
Publicado: (2021)

How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
por: Tiseo, Cindy, et al.
Publicado: (2019)

Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
por: Siddiqui, Mariah, et al.
Publicado: (2021)

Acupuncture as Treatment of Hot Flashes and the Possible Role of Calcitonin Gene-Related Peptide
por: Spetz Holm, Anna-Clara E., et al.
Publicado: (2012)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
por: Sánchez, Manuel Lisardo, et al.
Publicado: (2023)

Treatment of Cherubism with Salmon Calcitonin: A Case Report
por: Etoz, Osman A., et al.
Publicado: (2011)

PERCUTANEOUS TREATMENT OF ANEURYSMAL BONE CYST WITH CALCITONIN AND METHYLPREDNISOLONE
por: Oliveira, Marcelo Bragança dos Reis, et al.
Publicado: (2018)

Monoclonal therapy against calcitonin gene-related peptide lowers hyperglycemia and adiposity in type 2 diabetes mouse models
por: Halloran, Jonathan, et al.
Publicado: (2020)

Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
por: Siddiqui, Mariah, et al.
Publicado: (2021)

Efficacy and Safety of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Preventing Migraines: A Systematic Review
por: Muddam, Meghana Reddy, et al.
Publicado: (2023)

Polarity-specific modulation of pain processing by transcranial direct current stimulation – a blinded longitudinal fMRI study
por: Naegel, Steffen, et al.
Publicado: (2018)

Calcitonin gene-related peptide and menopause
por: Sharma, Sudhaa, et al.
Publicado: (2010)

Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis
por: Wang, Xing, et al.
Publicado: (2022)

Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
por: Ocheretyaner, Eric R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8oaa55uviirqnek774us2f7sus